Cases & Deals

REGENXBIO resolves patent dispute with Aldevron over patented host cells used in gene therapy applications

Client(s) REGENXBIO Inc.

Jones Day represented plaintiff REGENXBIO Inc. in a patent infringement case brought against Aldevron LLC claiming that without authorization, Aldevron used and manufactured cultured host cells containing recombinant nucleic acid molecules with sequences encoding AAV8 capsid protein(s) and a heterologous non-AAV sequence. These cultured host cells are used to replicate plasmid DNA used to make capsid proteins to package genes for gene therapy applications. The case was successfully resolved.

REGENXBIO Inc., et al. v. Aldevron LLC, No. 3-20-cv-00171 (D.N.D.)